Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 15,303.10 +8.60 0.06%
S&P 500 1,649.60 -0.91 -0.06%
Nasdaq 3,459.14 -0.27 -0.01%
Ticker Volume Price Price Delta
STOXX 50 2,764.29 -12.49 -0.45%
FTSE 100 6,654.34 -42.45 -0.63%
DAX 8,305.32 -46.66 -0.56%
Ticker Volume Price Price Delta
Nikkei 14,612.50 +128.47 0.89%
Hang Seng 22,618.70 -51.01 -0.23%
S&P/ASX 200 4,983.50 -78.95 -1.56%
  • Fund Type: SICAV
  • Objective: Sector Fund-Health & Biotech
  • Asset Class: Equity
  • Geographic Focus: Global

Bellevue Funds Lux - BB Biotech

+ Add to Watchlist

BBBIOGI:LX

197.80 GBP 0.33 0.17%

As of 08:16:00 ET on 05/23/2013.

Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Snapshot for Bellevue Funds Lux - BB Biotech (BBBIOGI)

Year To Date: +45.00% 3-Month: +25.58% 3-Year: - 52-Week Range: 125.78 - 200.64
1-Month: +4.47% 1-Year: +54.89% 5-Year: - Beta vs LUXXX: -

Mutual Fund Chart for BBBIOGI

No chart data available.
  • BBBIOGI:LX 197.80
  • 1M
  • 1Y
Interactive BBBIOGI Chart

Previous Close

Fund Profile & Information for BBBIOGI

Bellevue Funds (Lux) - BB Biotech is an open-end investment fund incorporated in Luxembourg. The Fund's objective is long-term capital appreciation. The Fund invests mainly in equities and equity related securities of companies that are directly involved in the biotechnology sector. The focus is on companies that develop, research, and market various technologies and products in this sector.

Inception Date: 03-30-2012 Telephone: 41-44-267-67-00
Managers: DANIEL KOLLER / TAZIO STORNI
Web Site: www.bellevuegroup.com

Fundamentals for BBBIOGI

NAV (on 2013-05-23) 197.80
Assets (M) (on 2013-05-23) 29.28
Fund Leveraged N
Minimum Investment 500,000.00
Minimum Subsequent Investment -

Dividends for BBBIOGI

No dividends reported

Fees & Expenses for BBBIOGI

Front Load -
Back Load 0.00
Current Mgmt Fee 0.90
Redemption Fee 0.00
12b1 Fee -
Expense Ratio -

Top Fund Holdings for BBBIOGI

Filing Date: 04/30/2013
Name Position Value % of Total
Gilead Sciences Inc 44,976 2,277,585 8.948%
Celgene Corp 18,702 2,208,145 8.676%
Biogen Idec Inc 9,387 2,055,096 8.074%
Regeneron Pharmaceuticals Inc 8,315 1,788,889 7.028%
Vertex Pharmaceuticals Inc 18,371 1,411,260 5.545%
Alexion Pharmaceuticals Inc 10,846 1,062,908 4.176%
Amgen Inc 9,866 1,028,136 4.039%
Onyx Pharmaceuticals Inc 9,017 854,812 3.358%
BioMarin Pharmaceutical Inc 12,831 841,714 3.307%
Medivation Inc 14,946 787,804 3.095%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Financial Commentaries

Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil